Concepedia
Statistics
Publications
10
Citations
1.3K
H-Index
Active since
1991
Affiliations
Sanofi (United States)(Current)
Pfizer (United States)
Health and Environmental Sciences Institute
Sanofi (France)
AstraZeneca (United Kingdom)
Ernie Harpur is an author at Sanofi (United States) specializing in toxicology, renal pathophysiology, and medicine.
Publications per year
1991–2014
A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity
Lutz Müller, Robert J. Mauthe, Christopher M. Riley et al. · Regulatory Toxicology and Pharmacology · 2006 · 461 citations
Pharmacy, Pharmaceutics, Toxicology +12
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium
Frank Dieterle, Frank D. Sistare, Federico Goodsaid et al. · Nature Biotechnology · 2010 · 406 citations
Medicine, Nephrology, Precision Medicine +13
Towards consensus practices to qualify safety biomarkers for use in early drug development
Frank D. Sistare, Frank Dieterle, Sean P. Troth et al. · Nature Biotechnology · 2010 · 121 citations
Pharmacy, Pharmacology, Regulatory Pharmacy +16
Biological Qualification of Biomarkers of Chemical-Induced Renal Toxicity in Two Strains of Male Rat
Ernie Harpur, Daniela Ennulat, David Hoffman et al. · Toxicological Sciences · 2011 · 121 citations · Full text
Medicine, Pathology, Toxicology +17
Evaluation of Novel Biomarkers of Nephrotoxicity in Two Strains of Rat Treated with Cisplatin
Jean‐Charles Gautier, Björn Riefke, Jakob Walter et al. · Toxicologic Pathology · 2010 · 87 citations
Medicine, Nephrology, Toxicology +16
1–5 of 10